Page last updated: 2024-10-20

pyridoxine and Myeloproliferative Disorders

pyridoxine has been researched along with Myeloproliferative Disorders in 2 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vacarezza, R1
Bottomley, SS1

Reviews

2 reviews available for pyridoxine and Myeloproliferative Disorders

ArticleYear
[Preleukemic states].
    Revista medica de Chile, 1982, Volume: 110, Issue:7

    Topics: Adrenal Cortex Hormones; Aged; Alkaline Phosphatase; Androgens; Antineoplastic Agents; Blood Cell Co

1982
Sideroblastic anaemia.
    Clinics in haematology, 1982, Volume: 11, Issue:2

    Topics: 5-Aminolevulinate Synthetase; Adult; Anemia, Sideroblastic; Blood Transfusion; Bone Marrow; Chloramp

1982